Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing
Journal of the Peripheral Nervous System · 2025
DOI: 10.1111/jns.70040 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Anthara Gnanakumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Student, George Washington University School of Medicine and Health Sciences, Washington, DC, USA. Hauptthemen laut MEDLINE: Leukodystrophy, Globoid Cell, Neonatal Screening, Peripheral Nervous System Diseases. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Introduction
Krabbe disease, or globoid cell leukodystrophy, is a rare autosomal recessive neurodegenerative disorder characterized by deficient activity of the lysosomal enzyme galactosylceramidase (GALC). This deficiency leads to the toxic accumulation of psychosine, resulting in progressive demyelination and neuronal death. The clinical manifestations of Krabbe disease progress through different stages, starting with irritability, stiffness, and feeding difficulties, followed by myoclonic‐like jerks in the upper and lower extremities, hypertonicity, and eventually severe hypotonia and lack of movement.
Methods
This case report features two newborn screening patients with (NBS)‐positive Krabbe disease who underwent electrodiagnostic (EDX) testing and hematopoietic stem cell transplantation (HSCT) soon after birth.
Results
The EDX results indicated severe sensory‐motor polyneuropathy of mixed demyelinating and axonal types. Biochemical analyses confirmed significantly reduced GALC enzyme activity and elevated psychosine levels in both cases. Genetic testing identified pathogenic variants, including compound heterozygous deletions and mutations within the GALC gene. At 6‐month follow‐up post‐HSCT, one patient showed age‐appropriate milestones and improvement in motor amplitudes on repeat nerve conduction studies.
Discussion
EDX testing is helpful in assessing NBS‐positive Krabbe disease before confirmatory testing results become available. In conjunction with genetic confirmation and GALC enzyme levels, EDX test results were useful to counsel families that their seemingly normal newborn has severe disease and facilitated discussion toward timely treatment with HSCT. We suggest that EDX be included in the initial and follow‐up evaluation of patients with Krabbe disease undergoing HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Student, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Department of Human Genetics, Emory University, School of Medicine, Atlanta, Georgia, USA.
- Department of Pediatrics, Emory University, School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: Sumit Verma
Zitieren
APA
Gnanakumar, A., Aljaberi, R., Laney, D. A., Martin, C., Keller, S. R., Parikh, S. H., & Verma, S. (2025). Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70040
Vancouver
Gnanakumar A, Aljaberi R, Laney DA, Martin C, Keller SR, Parikh SH, et al. Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70040
BibTeX
@article{Gnanakumar2025,
author = {Gnanakumar, Anthara and Aljaberi, Rana and Laney, Dawn A and Martin, Christian and Keller, Stephanie R and Parikh, Suhag H and Verma, Sumit},
title = {Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing},
journal = {Journal of the Peripheral Nervous System},
year = {2025},
doi = {10.1111/jns.70040}
}
EUVIMED